Stock Fundamentals

Company Information

Company Name
Incyte Corporation
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US45337C1027
CIK: 0000879169
CUSIP: 45337C102
Currency: USD
Full Time Employees: 2,844
Phone: 302 498 6700
Fiscal Year End: December
IPO Date: Nov 04, 1993
Description:

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refractory acute graft-versus-host disease; ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; MONJUVI/ MINJUVI for the treatment of diffuse large B-cell lymphoma and Follicular Lymphoma; NIKTIMVO for the treatment of chronic graft-versus-host disease. It also provides INCA033989 for the treatment of essential thrombocythemia and MF; INCA035784 for the treatment of anti-mutant calreticulin and myeloproliferative neoplasms (MPNs); INCB160058 for the treatment of MPNs; PEMAZYRE, a selective fibroblast growth factor receptor kinase inhibitor for the treatment of unresectable biliary tract cancer, metastatic cholangiocarcinoma, and myeloid/lymphoid neoplasms; ZYNYZ to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma. The company's clinical stage products include INCB123667 for ovarian cancer; INCB161734 for solid tumors; INCA33890 for cancers; Ruxolitinib cream for atopic dermatitis, hidradenitis suppurativa (HS), and prurigo nodularis; Povorcitinib for HS, nonsegmental vitiligo, prurigo nodularis, and asthma; and INCB00928 for the treatment of fibrodysplasia ossificans progressive. It has collaboration and license agreement with Novartis, Lilly, and Syndax. The company sells its products to specialty and retail pharmacies, hospital pharmacies, and distributors. The company was formerly known as Incyte Genomics Inc and changed its name to Incyte Corporation in March 2003. Incyte Corporation was incorporated in 1991 and is headquartered in Wilmington, Delaware.

Address:

1801 Augustine Cut-Off, Wilmington, DE, United States, 19803

Directors & Officers

Name Title Year Born
Mr. William J. Meury CEO & Director 1968
Dr. Pablo J. Cagnoni M.D., Ph.D. President and Global Head of R&D 1963
Mr. Thomas Tray Principal Financial Officer, VP of Finance & Chief Accounting Officer 1978
Dr. Steven H. Stein M.D. Executive VP, Head of Late-stage Development & Chief Medical Officer 1967
Mr. Mohamed Khairie Issa Executive Vice President & Head of U.S. Commercial 1983
Mr. Suketu P. Upadhyay Executive VP & CFO 1969
Mr. Michael James Morrissey Executive VP & Head of Global Technical Operations 1964
Ms. Alexis Smith Vice President & Head of Investor Relations NA
Mr. Richard A. Hoffman J.D., M.B.A. Executive VP & General Counsel NA
Ms. Pamela M. Murphy Vice President of Investor Relations & Corporate Communications 1951

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 17, 2026 Pablo J Cagnoni N/A Sale 18.67K $96.50 $1.80M
Mar 30, 2026 Ro Khanna N/A Purchase N/A $90.33 N/A
Mar 17, 2026 Pablo J Cagnoni N/A Sale 18.67K $94.24 $1.76M
Mar 10, 2026 Ro Khanna N/A Sale N/A $96.02 N/A
Jan 29, 2026 Ro Khanna N/A Purchase N/A $101.08 N/A
Jan 07, 2026 Mohamed Khairie Issa N/A Sale 10.86K $109.07 $1.18M
Dec 19, 2025 Thomas Tray N/A Sale 2.77K $100.00 $277.40K
Dec 18, 2025 Thomas Tray N/A Sale 600.00 $98.25 $58.95K
Dec 17, 2025 Michael James Morrissey N/A Sale 4.32K $97.26 $420.45K
Dec 16, 2025 Michael James Morrissey N/A Sale 54.01K $97.29 $5.25M
Dec 02, 2025 Steven H Stein N/A Sale 20.11K $102.51 $2.06M
Dec 01, 2025 Steven H Stein N/A Sale 2.56K $102.96 $263.47K
Nov 04, 2025 Sheila A Denton N/A Sale 598.00 $101.36 $60.61K
Nov 03, 2025 Lee Heeson N/A Sale 3.07K $94.02 $289.02K
Oct 15, 2025 Sheila A Denton N/A Sale 277.00 $85.13 $23.58K
Sep 16, 2025 Sheila A Denton N/A Sale 278.00 $83.15 $23.12K
Jul 21, 2025 Steven H Stein N/A Sale 3.71K $67.94 $251.79K
Jul 15, 2025 Barry P Flannelly N/A Sale 1.19K $69.86 $83.27K
Jul 15, 2025 Vijay K Iyengar N/A Sale 1.18K $69.86 $82.23K
Jul 14, 2025 Steven H Stein N/A Sale 14.95K $68.47 $1.02M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Baker Bros Advisors LP 30.74M Mar 31, 2026 15.39% $16.62 0.00%
Vanguard Group Inc 19.91M Dec 31, 2025 9.97% $0.03 -0.20%
BlackRock Inc 18.98M Mar 31, 2026 9.50% $0.03 3.55%
Dodge & Cox 12.25M Mar 31, 2026 6.13% $0.63 -7.61%
Vanguard Capital Management, LLC 10.93M Mar 31, 2026 5.47% $0.03 0.00%
State Street Corp 9.64M Mar 31, 2026 4.83% $0.03 -0.16%
Vanguard Portfolio Management, LLC 7.76M Mar 31, 2026 3.88% $0.04 0.00%
AQR Capital Management LLC 5.81M Mar 31, 2026 2.91% $0.25 -13.57%
Geode Capital Management, LLC 4.70M Mar 31, 2026 2.35% $0.03 -5.80%
LSV Asset Management 3.92M Mar 31, 2026 1.96% $0.80 -0.35%
Amvescap Plc. 3.87M Mar 31, 2026 1.94% $0.06 11.43%
Renaissance Technologies Corp 3.65M Mar 31, 2026 1.83% $0.54 -8.21%
Wellington Management Company LLP 3.27M Mar 31, 2026 1.63% $0.06 341.74%
Morgan Stanley - Brokerage Accounts 2.85M Mar 31, 2026 1.43% $0.02 7.00%
Arrowstreet Capital Limited Partnership 2.83M Mar 31, 2026 1.42% $0.14 -8.52%
Robeco Institutional Asset Management BV 2.51M Mar 31, 2026 1.26% $0.34 1.35%
The Goldman Sachs Group Inc 2.35M Mar 31, 2026 1.18% $0.03 83.16%
Los Angeles Capital Management LLC 2.14M Mar 31, 2026 1.07% $0.80 -6.29%
Dimensional Fund Advisors, Inc. 1.98M Mar 31, 2026 0.99% $0.04 10.48%
Acadian Asset Management LLC 1.90M Mar 31, 2026 0.95% $0.25 155.73%

Shares Statistics

Shares Outstanding: 199.78M
Shares Float: 167.50M
% Insiders: 188.50%
% Institutions: 10,657.80%
Short % Float: 9.83%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Dodge & Cox Stock I 8.28M 4.15% ▼ 7.86% Mar 31, 2026
2 Vanguard Total Stock Mkt Idx Inv 5.39M 2.70% ▲ 0.24% Apr 30, 2026
3 Vanguard 500 Index Investor 4.34M 2.17% ▲ 1.84% Apr 30, 2026
4 Vanguard Small Cap Index 3.90M 1.95% ▼ 0.21% Apr 30, 2026
5 Vanguard Health Care Inv 2.37M 1.18% ▲ 484.31% Mar 31, 2026
6 iShares Core S&P 500 ETF 2.20M 1.10% ▲ 0.31% May 29, 2026
7 Vanguard Small Cap Growth Index Inv 2.19M 1.09% ▼ 0.03% Apr 30, 2026
8 Fidelity 500 Index 2.14M 1.07% ▲ 0.35% Apr 30, 2026
9 State Street® SPDR® S&P 500® ETF 2.00M 1.00% ▲ 0.11% May 31, 2026
10 Invesco S&P 500® Equal Weight ETF 1.77M 0.89% ▲ 0.19% May 29, 2026

Valuation Metrics

Enterprise Value: $17.71B
Trailing P/E: 15.33
Forward P/E: 14.10

Financial Highlights

Market Cap: $21.68B
EBITDA: $1.55B
P/E Ratio: $15.33
PEG Ratio: $0.36
Book Value: $28.12
Earnings/Share: $7.08
Profit Margin: 26.71%
Operating Margin: 25.55%
ROA (TTM): 13.89%
ROE (TTM): 30.82%
Revenue (TTM): $5.36B
Revenue/Share (TTM): $27.27
Earnings Growth (YOY): 83.80%
Revenue Growth (YOY): 20.90%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 3.32x 0.00x 0.26x 553.04x 0.01x
2024-12-31 1.97x 0.01x 0.37x 44.43x 0.11x
2023-12-31 3.75x 0.01x 0.23x 256.90x 0.04x
2022-12-31 3.54x 0.01x 0.25x 221.92x 0.07x
2021-12-31 3.65x 0.01x 0.24x 307.01x 0.07x
2020-12-31 3.74x 0.01x 0.27x -121.29x -0.08x
2019-12-31 5.07x 0.02x 0.24x 216.71x 0.09x
2018-12-31 4.47x 0.02x 0.27x 83.75x 0.21x
2017-12-31 4.01x 0.01x 0.29x -35.27x -0.09x
2016-12-31 0.82x 3.11x 0.74x 3.74x 6.37x
2015-12-31 1.04x 7.24x 0.83x 1.11x 12.65x
2014-12-31 3.16x -8.44x 1.06x -0.10x 17.35x
2013-12-31 5.14x -3.43x 1.31x -0.42x -44.14x
2012-12-31 2.27x -1.89x 1.53x 0.02x 10.38x
2011-12-31 0.93x -2.71x 1.69x -3.27x -5.29x
2010-12-31 4.01x -3.31x 1.18x 0.32x 8.16x
2009-12-31 4.94x -4.33x 1.14x -4.35x -3.60x
2008-12-31 4.08x -1.93x 1.95x -6.39x -2.91x
2007-12-31 7.23x -2.57x 1.58x -3.55x -5.66x
2006-12-31 6.64x -4.56x 1.24x -4.29x -5.57x
2005-12-31 12.71x -18.56x 1.05x -6.28x -3.89x
2004-12-31 15.29x 5.06x 0.85x -8.63x -2.94x
2003-12-31 7.40x 1.09x 0.59x -18.70x -1.70x
2002-12-31 5.90x 0.64x 0.45x -14.06x -1.74x
2001-12-31 6.87x 0.43x 0.38x N/A -11.22x
2000-12-31 8.49x 0.30x 0.30x N/A -6.77x
1999-12-31 2.13x 0.00x 0.23x N/A 0.00x
1998-12-31 2.63x 0.00x 0.22x N/A 0.00x
1997-12-31 2.74x 0.00x 0.28x N/A 0.00x
1996-12-31 2.05x 0.00x 0.32x N/A -0.04x
1995-12-31 4.71x 0.00x 0.19x N/A -0.01x
1994-12-31 5.50x 0.00x 0.16x N/A -0.01x
1993-12-31 15.70x 0.02x 0.09x N/A -0.07x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about INCY.US!